Surviving crises
as filed7.2/10
Has it survived what it has been through?
No warning events in its filings since 2017.
weight 45% of this tense · 72nd percentile among 18 sector filers · read for itself
From the record
AMN Healthcare Services' filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Track record
as filed4.6/10
What has it actually done, year after year?
+4.1% a year over 10 filed years; profitable in 8 of 10.
weight 33% of this tense · 46th percentile among 18 sector filers · read for its customers
From the record
AMN Healthcare Services' 10 filed years say what it did: revenue went from $1.9 billion in fiscal 2016 to $2.7 billion in fiscal 2025, up 4.1% a year; it rose in 6 of 9 years; the deepest fall was 48% from fiscal 2022 to fiscal 2025; net income was positive in 8 of 10 of those years (its annual reports).
What it rests on
- revenue growth over the filed span4.1%top 47% of its family
- the share of years revenue rosetop 36% of its family
- the share of filed years with a profitbottom 47% of its family
- the deepest fall from a revenue peak47.9%bottom 19% of its family
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Shareholder treatment
as filed6.3/10
How has it treated the people who own it?
Share count shrank 5.0% a year. 44% of cash flow returned. Insiders: 2 sales, 0 purchases.
weight 22% of this tense · 63rd percentile among 14 sector filers · read for its shareholders
From the record
Over the 3 fiscal years to 2025-12-31, AMN Healthcare Services' diluted share count shrank about 5.0% a year, and dividends and buybacks returned about 44% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 2 sales (2 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-10-15 (their Form 4 filings).
What it rests on
- the share count over the yearstop 14% of its family
- cash returned against operating cash flowbottom 39% of its family
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.